← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Renova Therapeutics, Inc.
San Diego, CA
$3,685,663
Total funding
2
Grants
Funding over time
peak $805.7K · FY2014–23$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$3,685,663 · 2
By mechanism
R42$3,685,663 · 2
Investigators at Renova Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Urocortin-2 Gene Transfer for Type 1 Diabetes and Associated LV Dysfunction$805,659
R42 · FY2022 · HL
Urocortin-2 Gene Transfer for CHF: a Paracrine Approach Using Intravenous AAV8$802,500
R42 · FY2016 · HL
Urocortin-2 Gene Transfer for CHF: a Paracrine Approach Using Intravenous AAV8$802,500
R42 · FY2017 · HL
Urocortin-2 Gene Transfer for Type 1 Diabetes and Associated LV Dysfunction$792,556
R42 · FY2023 · HL
Urocortin-2 Gene Transfer for Type 1 Diabetes and Associated LV Dysfunction$241,698
R42 · FY2019 · HL
Urocortin-2 Gene Transfer for CHF: a Paracrine Approach Using Intravenous AAV8$240,750
R42 · FY2014 · HL